Statutory Liability for Misleading Advertisements and Celebrity Endorsements: CCPA Regulations under CPA 2019

I. I. The Commercial Power of Advertising and the Epidemic of Deceptive Claims

In India's hyper-competitive consumer marketplace, advertising represents the single most powerful driver of consumer behavior. FMCG giants, dietary supplement manufacturers, ed-tech unicorns, and cryptocurrency exchanges invest billions of rupees in sophisticated multimedia advertising campaigns across television, social media, and digital platforms. To manufacture immediate consumer trust, brands heavily recruit Bollywood actors, elite cricket athletes, and viral digital influencers as celebrity brand ambassadors.

However, the commercial allure of celebrity endorsements frequently conceals fraudulent product realities. Consumers are inundated with unsubstantiated scientific claims: hair oils promising to reverse baldness within fourteen days, dietary pills claiming miraculous weight loss without exercise, coaching institutes fabricating examination rank toppers, and financial schemes promising guaranteed 50% returns.

Prior to 2019, regulatory oversight was fragmented under toothless industry self-regulatory bodies like the Advertising Standards Council of India (ASCI), whose non-binding directives were routinely ignored. With the enactment of the Consumer Protection Act, 2019, and the notification of the *Guidelines for Prevention of Misleading Advertisements and Endorsements for Misleading Advertisements, 2022*, Parliament established an uncompromising statutory regime holding manufacturers, advertising agencies, and celebrity endorsers directly liable.

II. II. Defining Misleading Advertisements under Section 2(28) of the CPA 2019

Section 2(28) of the Consumer Protection Act, 2019, establishes an exhaustive, four-pronged statutory definition of a 'Misleading Advertisement'. An advertisement is statutorily misleading if it:

(a) falsely describes such product or service; or (b) gives a false guarantee to, or is likely to mislead the consumers as to the nature, substance, quantity or quality of such product or service; or (c) conveys an express or implied representation which, if made by the manufacturer or seller or service provider thereof, would constitute an unfair trade practice; or (d) deliberately conceals important information.

Crucially, Section 2(28)(d) establishes that the deliberate omission or concealment of material facts (such as critical health side effects, hidden mandatory recurring fees, or unrealistic testing conditions) renders an advertisement legally misleading, even if every positive statement made is technically true. The overall net impression on an ordinary consumer governs liability.

III. III. CCPA Powers and Penalties under Section 21: Manufacturer and Endorser Exposure

The enforcement of advertising standards is vested in the Central Consumer Protection Authority (CCPA) under Section 10 of the CPA 2019. Section 21 arms the CCPA with sweeping regulatory and penal powers to sanction misleading advertisements.

Under Section 21(1), where the CCPA is satisfied after investigation that any advertisement is false or misleading, it may issue directions to the concerned trader, manufacturer, endorser, advertiser or publisher to discontinue or modify the advertisement.

Furthermore, under Section 21(2), the CCPA can impose a financial penalty on a manufacturer or advertiser of up to **INR 10 Lakhs** for a first-time violation, scaling up to **INR 50 Lakhs** for subsequent violations. Under Section 21(3), the CCPA possesses the extraordinary power to impose an identical financial penalty of up to **INR 10 Lakhs** directly upon the **Celebrity Endorser**.

Most critically, under Section 21(4), the CCPA is empowered to prohibit the endorser of a misleading advertisement from making any endorsement of *any product or service* for a period which may extend to **one year**, and up to **three years** for subsequent contraventions—a commercial death sentence for celebrity ambassadors.

IV. IV. The Statutory Due Diligence Defense for Celebrity Endorsers under Section 21(5)

Parliament recognized that celebrity endorsers are not scientists or laboratory technicians; an actor cannot independently conduct chemical chromatography on an energy drink. Therefore, Section 21(5) establishes a vital statutory safe harbor defense.

Section 21(5) provides: 'No endorser shall be liable to a penalty under sub-sections (2) and (3) if he has exercised **due diligence to verify the veracity of the claims** made in the advertisement regarding the product or service in respect of which the endorsement is made.'

The 2022 Guidelines establish what constitutes lawful 'due diligence'. To claim Section 21(5) immunity, the celebrity endorser must maintain a documented compliance trail: reviewing scientific laboratory certifications (NABL-accredited test reports), verifying statutory licenses (FSSAI licenses for food, CDSCO for cosmetics), obtaining written legal representations from the manufacturer, and ensuring that personal experience claims reflect bona fide personal use. Signing an endorsement contract without inspecting underlying substantiation documents destroys statutory immunity.

V. V. Surrogate Advertising, Disclaimers, and Social Media Influencer Disclosures

The 2022 CCPA Guidelines vigorously target 'Surrogate Advertising'. In India, direct advertising of alcoholic beverages, tobacco products, and gambling is statutorily banned. Liquor conglomerates routinely deploy surrogate campaigns, advertising packaged drinking water, club soda, or music CDs using identical brand names, fonts, and visual motifs.

Guideline 6 strictly prohibits surrogate advertising: an advertisement for a permissible product is deemed an unlawful surrogate advertisement if it uses the brand name, logo, or visual layout of a restricted product, or if the permissible product lacks independent, substantial commercial production. The CCPA has issued multi-crore penalty notices to alcohol conglomerates and celebrities participating in surrogate campaigns.

In addition, the Guidelines regulate digital influencers. Any digital content creator receiving monetary compensation, free products, hotel stays, or affiliate commissions must prominently display an unambiguous disclosure label (#Ad, #Sponsored, #PaidPartnership) at the beginning of the video or post, ensuring immediate consumer transparency.

VI. VI. Chambers Advertising Law and Celebrity Representation Practice

Advocate Ritik Khurana Chambers provides specialized advertising compliance advisory, brand risk auditing, and regulatory defense representation before the Central Consumer Protection Authority and Consumer Commissions across India. We advise corporate brands, advertising agencies, production houses, and high-profile celebrity endorsers.

Our practice drafts Comprehensive Celebrity Endorsement Agreements, structuring robust Section 21(5) Due Diligence Dossiers, manufacturer indemnity covenants, and product substantiation verifications. In regulatory show-cause proceedings initiated by the CCPA or criminal investigations regarding deceptive advertising, our litigation team delivers aggressive defense representation.

In the modern commercial landscape, creative marketing must be anchored in rigorous statutory truth; our chambers ensures your brand campaigns captivate consumers while standing completely unassailable under regulatory scrutiny.